Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure

Overview of attention for article published in Frontiers in oncology, January 2024

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 3 X users, with an upper bound of 36,611 followers.

RT @DrImranSheikh: Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative bre…

18 Jan 2024

Reply Repost Favourite

Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure: Continuous low-dose 5-FU was popularized as a therapy for…… #oncology https://t.co/2JqDi

18 Jan 2024

Reply Repost Favourite

RT @FrontOncology: New research: Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV tripl…

16 Jan 2024

Reply Repost Favourite

New research: Case report: An exceptional responder of low-dose continuous 5-FU in a patient with de-novo stage IV triple-negative breast cancer with liver and bone marrow failure: Continuous low-dose 5-FU was popularized as a therapy for… https://t.co/N9X

15 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.